citric acid, anhydrous has been researched along with taurolidine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Feldmer, B; Polaschegg, HD; Sodemann, K | 1 |
| Forneris, G; Quarello, F | 1 |
| Betjes, MG; van Agteren, M | 1 |
| Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D | 1 |
| Filiopoulos, V; Hadjiyannakos, D; Koutis, I; Lazarou, D; Micha, T; Trompouki, S; Vlassopoulos, D | 1 |
| Chen, L; Deng, J; Liu, H; Wu, Y; Yuan, L | 1 |
| Campistol, JM; Cardozo, C; Donate, J; Fontseré, N; Maduell, F; Mensa, J; Muros, M; Navarro-González, JF; Pons, M; Soriano, A | 1 |
| Deighan, C; Geddes, C; Murray, EC; Thomson, PC | 1 |
| LaPlante, KL; Luther, MK; Mermel, LA | 1 |
| Goulet, O; Lambe, C; Poisson, C; Talbotec, C | 1 |
| Clark, JE; Graham, N; Kleidon, T; Ullman, A | 1 |
| Girardot, T; Monard, C; Rimmelé, T | 1 |
| Bueloni, TNV; Caetano, C; de Souza Cavalcante, R; Marchi, D; Mendes Amaral, ML; Ponce, D | 1 |
| Chan, MY; Chong, CY; Lim, AS; Ong, C; Ong, RY; Seah, VX; Soh, SY; Tan, NW; Thoon, KC | 1 |
| Calvo, M; Coll, E; Compte, MT; Filella, X; Fontsere, N; Graterol, F; Jiménez Hernández, M; Maduell, F; Poch, E; Rebled, JM; Soriano, A | 1 |
| Elsharkawy, M; Emara, A; Ezzat, H; Mansour, A; Mohsen, R; Rezk, K | 1 |
| Abrahams, AC; Dekker, FW; Meijvis, SCA; Rotmans, JI; van Oevelen, M; van Roeden, S | 1 |
| Fiocco, M; Frakking, FNJ; Loeffen, Y; van de Ven, CP; van de Wetering, MD; van den Bosch, CH; van der Bruggen, JT; van der Steeg, AFW; Wijnen, MHWA | 1 |
| Ait Hammou Taleb, MH; Mahmutovic, M; Malgras, A; Michot, N; Nguyen-Thi, PL; Quilliot, D | 1 |
4 review(s) available for citric acid, anhydrous and taurolidine
| Article | Year |
|---|---|
Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock.
Topics: Anti-Infective Agents, Local; Catheters, Indwelling; Citric Acid; Equipment Contamination; Equipment Design; Humans; Infection Control; Renal Dialysis; Sepsis; Taurine; Thiadiazines | 2002 |
Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis.
Topics: Anti-Infective Agents; Anticoagulants; Bacteremia; Citric Acid; Female; Humans; Male; PubMed; Taurine; Thiadiazines; Vascular Access Devices | 2014 |
Dialysis catheters in the ICU: selection, insertion and maintenance.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citric Acid; Equipment Design; Humans; Intensive Care Units; Randomized Controlled Trials as Topic; Renal Dialysis; Taurine; Thiadiazines | 2018 |
Effectiveness of salvage catheters in home parenteral nutrition: A single-center study and systematic literature review.
Topics: Adult; Anti-Bacterial Agents; Catheter-Related Infections; Central Venous Catheters; Citrates; Citric Acid; Humans; Observational Studies as Topic; Parenteral Nutrition, Home | 2023 |
7 trial(s) available for citric acid, anhydrous and taurolidine
| Article | Year |
|---|---|
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Topics: Anti-Infective Agents; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; Citric Acid; Equipment Contamination; Female; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sepsis; Solutions; Taurine; Thiadiazines | 2004 |
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Anticoagulants; Bacteremia; Catheters, Indwelling; Citric Acid; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Heparin; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Taurine; Thiadiazines | 2010 |
Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Citric Acid; Female; Gentamicins; Heparin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Taurine; Thiadiazines | 2011 |
Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Catheter-Related Infections; Cefazolin; Central Venous Catheters; Citric Acid; Device Removal; Female; Gentamicins; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Factors; Taurine; Thiadiazines | 2019 |
Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Topics: Adolescent; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Child; Child, Preschool; Citrates; Citric Acid; Hematology; Humans; Taurine; Thiadiazines | 2020 |
Effect of taurolidine citrate and unfractionated heparin on inflammatory state and dialysis adequacy in hemodialysis patients.
Topics: Anticoagulants; C-Reactive Protein; Catheter-Related Infections; Central Venous Catheters; Citrates; Citric Acid; Heparin; Humans; Inflammation; Interleukin-6; Renal Dialysis | 2023 |
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
Topics: Catheter-Related Infections; Central Venous Catheters; Child; Citrates; Citric Acid; Heparin; Humans; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Sepsis | 2023 |
8 other study(ies) available for citric acid, anhydrous and taurolidine
| Article | Year |
|---|---|
Two years' experience with Dialock and CLS (a new antimicrobial lock solution).
Topics: Adult; Anti-Infective Agents; Anticoagulants; Catheterization, Central Venous; Catheters, Indwelling; Citric Acid; Equipment Design; Femoral Vein; Heart Atria; Humans; Incidence; Infection Control; Jugular Veins; Kidney Failure, Chronic; Pilot Projects; Renal Dialysis; Retrospective Studies; Risk Assessment; Safety; Sepsis; Solutions; Subclavian Vein; Taurine; Thiadiazines | 2001 |
Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; C-Reactive Protein; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Female; Heparin; Humans; Inflammation; Interleukin-10; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; RNA, Messenger; Taurine; Thiadiazines; Tumor Necrosis Factor-alpha | 2014 |
Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.
Topics: Anti-Infective Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Central Venous Catheters; Citric Acid; Drug Combinations; Equipment Contamination; Heparin; Humans; Prospective Studies; Renal Dialysis; Staphylococcal Infections; Taurine; Thiadiazines | 2014 |
Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous cat
Topics: Anti-Infective Agents; Anticoagulants; Central Venous Catheters; Citric Acid; Colony Count, Microbial; Emulsions; Heparin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Temperature; Thiadiazines; Time Factors; Vancomycin | 2014 |
Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
Topics: Anti-Infective Agents; Calcium Chelating Agents; Catheter-Related Infections; Child; Child, Preschool; Citric Acid; Cohort Studies; Female; France; Humans; Infant; Intestinal Diseases; Male; Parenteral Nutrition, Home; Prospective Studies; Taurine; Thiadiazines; Treatment Outcome | 2018 |
Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.
Topics: Adolescent; Anti-Infective Agents, Local; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Central Venous Catheters; Child; Child, Preschool; Citric Acid; Cross Infection; Female; Gram-Negative Bacteria; Humans; Infant; Male; Taurine; Thiadiazines | 2019 |
Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Citric Acid; Equipment Design; Female; Heparin; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Pilot Projects; Prospective Studies; Renal Dialysis; Surface Properties; Taurine; Thiadiazines; Time Factors; Treatment Outcome | 2021 |
The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.
Topics: Aged; Anticoagulants; Catheter-Related Infections; Catheters, Indwelling; Central Venous Catheters; Citric Acid; Equipment Failure; Female; Heparin; Humans; Male; Middle Aged; Retrospective Studies; Taurine; Thiadiazines | 2021 |